Drug interaction risk between cardioprotective drugs and drugs used in treatment of COVID-19: A evidence-based review from six databases

BACKGROUND AND AIMS: This Review discusses the potential drug interactions risk between Drugs used in treating COVID-19 infection and Drugs used in treating comorbid conditions (Diabetes, hypertension, cardiovascular illness). METHOD: Six Databases were consulted a) Micromedex drug interaction b) Me...

Descripción completa

Detalles Bibliográficos
Autores principales: S K, Shini Rubina, P A, Anuba, B, Swetha, kalala, Kavya Priya, PM, Aishwarya, Sabarathinam, Sarvesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Diabetes India. Published by Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898923/
https://www.ncbi.nlm.nih.gov/pubmed/35279008
http://dx.doi.org/10.1016/j.dsx.2022.102451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898923/
https://www.ncbi.nlm.nih.gov/pubmed/35279008
http://dx.doi.org/10.1016/j.dsx.2022.102451

Ejemplares similares